BUSINESSWEEK ONLINE : OCTOBER 16, 2000 ISSUE
FINANCE

Mutual Funds Invest in Private Biotech Ventures


                                                      AMOUNT
FUND                                                (millions)

JANUS GLOBAL LIFE SCIENCES                            $122.0
H&Q HEALTHCARE INVESTORS (closed-end fund)              83.4
H&Q LIFE SCIENCES INVESTORS (closed-end fund)           59.2
ORBITEX LIFE SCIENCES & BIOTECH FUND                    25.0*
EATON VANCE WORLDWIDE HEALTH SCIENCES, A SHARES          8.8
MUNDER FRAMLINGTON HEALTHCARE, Y SHARES                  3.6
ORBITEX HEALTH & BIOTECH FUND                            3.5
DRESDNER RCM BIOTECHNOLOGY, N SHARES                     3.0


* New fund; proposed limit

DATA: BUSINESS WEEK, MORNINGSTAR INC.


_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _


RELATED ITEMS
Biotechs Are Cloning Money

CHART: Biotech Shines Even in a Weak Market

TABLE: Mutual Funds Invest in Private Biotech Ventures



INTERACT
E-Mail to Business Week Online

 
Copyright 2000-2008, by The McGraw-Hill Companies Inc. All rights reserved.
Terms of Use   Privacy Notice